D72.111 Lymphocytic Variant Hypereosinophilic Syndrome [LHES]

✓ Billable ICD-10-CM 2026
Open D72.111 in Web App →

The ICD-10-CM code for Lymphocytic Variant Hypereosinophilic Syndrome [LHES] is D72.111 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
D70-D77: Other disorders of blood and blood-forming organs (D70-D77)
Category D72
28 codes (22 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to D72.111:

  • Syndrome › hypereosinophilic (HES) › lymphocytic variant (LHES)
Code Also
  • , if applicable, any associated lymphocytic neoplastic disorder

Inclusion Terms

  • Lymphocyte variant hypereosinophilia

U.S. Hospital Utilization

D72.111 appeared in too few sampled U.S. inpatient stays in 2023 to report a national estimate (AHRQ suppresses counts of 10 or fewer) — a rare inpatient diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Chapter 3 TOC entry

3. Chapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) ............................................................................................. 39

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.3
Reserved for future guideline expansion

Reserved for future guideline expansion ...................................................................................... 39

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.3.Reserved

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial